Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
1999 8
2000 7
2001 2
2002 1
2003 2
2004 1
2006 1
2007 9
2008 5
2009 3
2010 3
2011 4
2012 9
2013 4
2014 1
2015 1
2016 2
2017 7
2018 12
2019 13
2020 15
2021 31
2022 32
2023 25
2024 32
2025 35
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
Sayar E, Patel RA, Coleman IM, Roudier MP, Zhang A, Mustafi P, Low JY, Hanratty B, Ang LS, Bhatia V, Adil M, Bakbak H, Quigley DA, Schweizer MT, Hawley JE, Kollath L, True LD, Feng FY, Bander NH, Corey E, Lee JK, Morrissey C, Gulati R, Nelson PS, Haffner MC. Sayar E, et al. Among authors: hanratty b. JCI Insight. 2023 Apr 10;8(7):e162907. doi: 10.1172/jci.insight.162907. JCI Insight. 2023. PMID: 36821396 Free PMC article.
Patterns of intra- and intertumor phenotypic heterogeneity in lethal prostate cancer.
Roudier MP, Gulati R, Sayar E, Patel RA, Tratt M, Richards HM, Cejas P, Munoz Gomez M, Qiu X, Xie Y, Hanratty B, Zaidi S, Zhao JL, Adil M, Mittal C, Zhao Y, Dumpit R, Coleman I, Low JY, Persse T, Galipeau P, Lee JK, Tretiakova M, Chambers M, Vakar-Lopez F, True LD, Perrone M, Lam HM, Kollath LA, Ding CC, Harmon S, Cheng HH, Yu EY, Montgomery RB, Hawley JE, Lin DW, Corey E, Schweizer MT, Setty M, Ha G, Sawyers CL, Morrissey C, Long H, Nelson PS, Haffner MC. Roudier MP, et al. Among authors: hanratty b. J Clin Invest. 2025 Jun 10;135(15):e186599. doi: 10.1172/JCI186599. eCollection 2025 Aug 1. J Clin Invest. 2025. PMID: 40493417 Free PMC article.
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology.
Bose A, Bankhead A 3rd, Coleman I, Persse T, Han W, Galipeau P, Hanratty B, Chu T, Lucas J, Li D, Bilkis R, Itagi P, Hassan S, Beightol M, Ko M, Dumpit R, Haffner M, Pritchard C, Ha G, Nelson PS. Bose A, et al. Among authors: hanratty b. J Clin Invest. 2025 Sep 16;135(22):e194727. doi: 10.1172/JCI194727. eCollection 2025 Nov 17. J Clin Invest. 2025. PMID: 40956611 Free PMC article.
PROX1 is an early driver of lineage plasticity in prostate cancer.
Duan Z, Shi M, Kumaraswamy A, Lin D, Khokhani D, Wang Y, Zhang C, Flores D, Rodansky E, Swaim OA, Storck WK, Beck HN, Patel RA, Sayar E, Hanratty BP, Xue H, Dong X, Maylin ZR, Wan R, Quigley DA, Sjöström M, Hu YM, Zhao F, Xia Z, Cheng S, Yu X, Feng FY, Zhang L, Aggarwal R, Small EJ, Ravikumar V, Rao A, Bedi K, Lee JK, Morrissey C, Coleman I, Nelson PS, Corey E, Udager AM, Rebernick RJ, Cieslik MP, Chinnaiyan AM, Yates JA, Haffner MC, Wang Y, Alumkal JJ. Duan Z, et al. Among authors: hanratty bp. J Clin Invest. 2025 Jun 2;135(11):e187490. doi: 10.1172/JCI187490. eCollection 2025 Jun 2. J Clin Invest. 2025. PMID: 40454483 Free PMC article.
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.
Westaby D, Jiménez-Vacas JM, Figueiredo I, Rekowski J, Pettinger C, Gurel B, Lundberg A, Bogdan D, Buroni L, Neeb A, Padilha A, Taylor J, Zeng W, Das S, Hobern E, Riisnaes R, Crespo M, Miranda S, Ferreira A, Hanratty BP, Nava Rodrigues D, Bertan C, Seed G, Fenor de La Maza MLD, Guo C, Carmichael J, Grochot R, Chandran K, Stavridi A, Varkaris A, Stylianou N, Hollier BG, Tunariu N, Balk SP, Carreira S, Yuan W, Nelson PS, Corey E, Haffner M, de Bono J, Sharp A. Westaby D, et al. Among authors: hanratty bp. J Clin Invest. 2024 Sep 17;134(18):e179998. doi: 10.1172/JCI179998. J Clin Invest. 2024. PMID: 39286979 Free PMC article.
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.
Ajkunic A, Sayar E, Roudier MP, Patel RA, Coleman IM, De Sarkar N, Hanratty B, Adil M, Zhao J, Zaidi S, True LD, Sperger JM, Cheng HH, Yu EY, Montgomery RB, Hawley JE, Ha G, Persse T, Galipeau P, Lee JK, Harmon SA, Corey E, Lang JM, Sawyers CL, Morrissey C, Schweizer MT, Gulati R, Nelson PS, Haffner MC. Ajkunic A, et al. Among authors: hanratty b. NPJ Precis Oncol. 2024 May 17;8(1):104. doi: 10.1038/s41698-024-00599-6. NPJ Precis Oncol. 2024. PMID: 38760413 Free PMC article.
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.
De Sarkar N, Patton RD, Doebley AL, Hanratty B, Adil M, Kreitzman AJ, Sarthy JF, Ko M, Brahma S, Meers MP, Janssens DH, Ang LS, Coleman IM, Bose A, Dumpit RF, Lucas JM, Nunez TA, Nguyen HM, McClure HM, Pritchard CC, Schweizer MT, Morrissey C, Choudhury AD, Baca SC, Berchuck JE, Freedman ML, Ahmad K, Haffner MC, Montgomery RB, Corey E, Henikoff S, Nelson PS, Ha G. De Sarkar N, et al. Among authors: hanratty b. Cancer Discov. 2023 Mar 1;13(3):632-653. doi: 10.1158/2159-8290.CD-22-0692. Cancer Discov. 2023. PMID: 36399432 Free PMC article.
272 results